Consensus Ipsen

Equities

IPN

FR0010259150

Market Closed - Euronext Paris Other stock markets 11:35:01 2024-05-06 am EDT			After market 12:04:13 pm
114.6 ^EUR	+0.09%		114.6	0.00%

May. 02	Ipsen Announces Executive Changes	CI
May. 02	Ipsen: new President for North America	CF

Evolution of the average Target Price on Ipsen

Price target over the last 5 years

History of analyst recommendation changes

c8f62a745bec67190502f9d516.OToYfSYKRGG0pSiM3hsXlnrxe4uJSQ8kNB-k1zWKhb8.cVNqNGNZcRCN8WTWkWo6pg7cL7_WcHdqBWzT7kHZ08l6Y1U6QzInLN3QHA~fc07eec3dbfbf19962033e6c44d1b000

Analyst Recommendations on Ipsen

IPSEN : Better-than-expected Q1; guidance unchanged	Apr. 24
IPSEN : Ipsen’s underlying fundamentals remain promising	Mar. 13
Deutsche Bank Reduces Ipsen PT, Keeps Hold Rating	Feb. 16	MT
IPSEN : Deutsche Bank cuts its target	Feb. 16	CF
IPSEN : UBS reiterates its buy recommendation	Feb. 14	CF
IPSEN : In line Q4 sales; lower-than-expected 2024 guidance	Feb. 08
IPSEN : Deutsche Bank lowers its target price	Dec. 15	CF
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD	Dec. 08
IPSEN : UBS remains Buy after CMD	Dec. 08	CF
IPSEN : RBC maintains 'in-line performance' rating	Nov. 29	CF
IPSEN : Jefferies downgrades recommendation to 'hold	Nov. 20	CF
IPSEN : Modest Q3 sales growth; guidance unchanged	23-10-26
Ipsen: upbeat with broker upgrade	23-09-12	CF
UBS Upgrades Ipsen to Buy from Neutral, Boosts PT	23-09-12	MT
IPSEN : UBS raises its recommendation	23-09-12	CF
IPSEN : RBC welcomes Cabometyx data	23-08-21	CF
IPSEN : AlphaValue upgrades its recommendation to 'buy	23-08-08	CF
IPSEN : Deutsche Bank raises its price target	23-08-08	CF
IPSEN : A compelling small Pharma	23-08-07
IPSEN : Healthy Q2 sales + a guidance upgrade	23-07-27
IPSEN : Healthy Q1 sales; full-year guidance maintained	23-04-27
IPSEN : Promising end to 2022	23-04-17
IPSEN : Oddo raises its target price	23-02-13	CF
IPSEN : Promising end to 2022	23-02-09
IPSEN : UBS reiterates its recommendation on the stock	23-01-24	CF